Intelligent Leadership, Precision and Efficiency: Raytor Instruments Successfully Finishes 2025 National Pharmaceutical R&D Innovation Conference

The two-day "2025 National Pharmaceutical R&D Innovation, Investment and M&A Conference" was successfully concluded at Sheraton Jinan Hotel. As a leading dissolution testing solution provider in China, Raytor Instruments, with its intelligent flagship product matrix--RT612-ST Automated Dissolution System and RT800 Automated Transdermal Diffusion System, made a wonderful appearance at Booth A20.

This conference focuses on the cutting-edge technology and capital trends in pharmaceutical R&D, and the booth of Raytor Instruments became one of the focuses of attention on the spot.

Two innovative highlights to empower drug development:

RT612-ST Automated Dissolution System: Designed for high-throughput, multi-time-point sampling needs, this system greatly improves the reproducibility of experiments through precise automation and significantly reduces the time of manual intervention by analysts, reflecting the depth of Rieter's automation field.

RT800 Automated Transdermal Diffusion System: As Raytor's flagship transdermal testing platform, the new RT800 fully meets the strict pharmacopoeia and mechanical validation guidelines at home and abroad, providing a solid foundation for drug quality control.

The exhibition team of Raytor Instruments had an in-depth technical exchange and cooperation discussion with pharmaceutical R&D experts, investment organizations and enterprise representatives from all over the country. We deeply felt that the industry has a strong demand for efficient, intelligent and compliant dissolution testing equipment.

In the future, Raytor Instruments will continue to uphold the concept of "Innovation, Professionalism and Compliance" and help China's pharmaceutical R&D to a higher level with better products and services. Thank you for visiting our booth A20, and we look forward to our next meeting!